Effects of other deprivation

ST19_EFFEC_OTHER_DEPRI

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — T73 Cause of death: ICD-10 — T73 2 out of 7 registries used, show all original rules.	104
4. Check minimum number of events None	104
5. Include endpoints None	104
6. Filter based on genotype QC (FinnGen only)	91

Control definitions (FinnGen only)

Control exclude: ST19_OTHER_UNSPE_EFFEC_EXTER_CAUSES

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: T6[6-9]|T7[0-8]
Name in latin: Effectus aliarum privationum

NAME	ST19_EFFEC_OTHER_DEPRI
CONTROL_EXCLUDE	ST19_OTHER_UNSPE_EFFEC_EXTER_CAUSES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	T73
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	T73
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Effects of other deprivation based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	91	56	35
Unadjusted period prevalence (%)	0.02	0.02	0.02
Median age at first event (years)	38.08	40.55	34.11

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
95: Matched controls
950

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

T73.3

ICD-10 Finland

Exhaustion due to excessive exertion

2821.3

90.5

F32.9

ICD-10 Finland

Depressive episode, unspecified

4.1

7.8

T73.0

ICD-10 Finland

Effects of hunger

+∞

6.3

T73.9

ICD-10 Finland

Effect of deprivation, unspecified

+∞

6.3

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

16.4

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

3.60

2.69

1.7

1.3

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

282

1.96

2.58

4.8

3.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

189

1.95

2.25

1.8

2.0

0.63

1.12

mg/l

1.19

139

(3028300) Cannabinoids [Presence] in Urine

2.48

2.20

1.9

1.7

—

(3000764) Benzodiazepines [Presence] in Urine

2.48

2.20

1.9

1.7

—

(3027008) Opiates [Presence] in Urine

2.48

2.20

1.9

1.7

—

(3027944) Amphetamines [Presence] in Urine

2.48

2.20

1.9

1.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2.39

2.18

1.0

1.4

34.80

150.22

u/ml

—

(3003396) Base excess in Arterial blood by calculation

2.17

1.88

2.6

9.1

0.01

1.42

mmol/l

—

(3016879) Cocaine [Presence] in Urine

2.35

1.88

2.0

1.7

—

(3001604) Monocytes [#/volume] in Blood

430

1.74

1.84

6.8

6.2

0.59

0.57

e9/l

0.39

383

(3015377) Calcium [Moles/volume] in Serum or Plasma

273

1.73

1.77

8.3

3.3

2.35

mmol/l

0.11

247

(3019198) Lymphocytes [#/volume] in Blood

443

1.72

1.76

6.8

6.2

1.90

1.89

e9/l

0.01

403

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

1.76

0.0

1.3

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

338

1.70

1.74

9.0

5.3

37.64

36.57

g/l

0.56

328

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

166

1.78

1.60

1.5

1.3

0.90

8.48

u/ml

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

158

1.79

1.59

3.6

3.2

24.56

153.07

ng/l

1.63

110

(3006315) Basophils [#/volume] in Blood

431

1.66

1.58

6.9

6.2

0.05

0.04

e9/l

0.67

382

(1001926) Buprenorphine [Presence] in Urine by Screen method

2.31

1.57

2.2

1.7

—

(3037522) Nuclear Ab [Titer] in Serum

126

1.86

1.57

1.3

1.5

256.00

564.14

titre

—

(3011288) Drugs identified in Urine by Screen method Nominal

2.37

1.52

2.4

1.9

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

3.24

1.45

2.0

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

138

1.77

1.42

5.3

2.8

25.82

3.27

e6/l

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1.96

1.41

2.7

8.8

4.78

5.07

kpa

0.87

(3027801) Oxygen [Partial pressure] in Arterial blood

1.96

1.41

2.7

8.8

13.79

12.87

kpa

0.24

(1002224) Polysomnography panel

2.26

1.39

1.2

1.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

2.60

1.32

1.0

1.1

—

(40758558) Short blood count panel - Blood

236

1.61

1.32

10.8

7.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

295

1.55

1.22

3.4

3.1

17.67

35.88

ng/l

0.96

170

(42870588) Differential panel, method unspecified - Blood

286

1.55

1.21

6.7

5.9

—

(40760892) CBC W Ordered Manual Differential panel - Blood

205

1.60

1.21

2.2

4.9

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2.39

1.20

2.7

1.6

0.20

0.24

g/l

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

2.39

1.20

3.0

1.6

23.83

24.15

mmol/l

—

(3022145) Colonoscopy Study observation

1.84

1.20

1.2

1.4

—

(3023368) Bacteria identified in Blood by Culture

215

1.58

1.18

3.4

4.4

—

(3021589) Normoblasts [#/volume] in Blood

363

1.52

1.18

8.1

10.9

0.00

0.01

e9/l

0.50

297

(3019150) Specific gravity of Urine by Refractometry

182

1.59

1.12

4.5

3.3

1.02

kg/l

0.38

114

(3000494) Fungus identified in Specimen by Culture

1.77

1.08

1.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

447

1.48

1.06

4.3

3.5

0.00

estimate

—

(4094501) Cardiovascular stress test using bicycle ergometer

2.34

1.04

1.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

324

1.47

1.01

4.4

3.4

0.00

estimate

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

2.02

0.99

1.3

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

145

1.58

0.95

2.0

2.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

225

1.49

0.95

1.3

1.4

0.70

1.36

u/ml

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

216

1.49

0.94

2.0

1.7

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

485

1.44

0.92

11.6

11.8

3.87

4.15

e9/l

0.54

435

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.81

0.90

1.4

2.0

—

(3002582) Erythrocytes [#/volume] in Urine

264

1.45

0.90

5.6

3.2

17.24

56.75

e6/l

0.88

198

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

130

1.58

0.90

1.8

2.1

—

(3030467) Casts [#/volume] in Urine by Automated count

228

1.46

0.88

4.5

3.1

0.08

0.28

e6/l

1.37

163

(3048689) Calprotectin [Mass/mass] in Stool

114

1.60

0.87

1.9

2.1

53.11

85.43

ug/g

—

(3028707) Methadone [Presence] in Urine by Screen method

1.93

0.83

3.0

1.8

—

(3037467) Urinalysis macro (dipstick) panel - Urine

562

1.43

0.83

6.1

4.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.87

0.80

1.0

1.2

—

(3035350) Ketones [Presence] in Urine by Test strip

454

1.38

0.78

4.4

3.5

0.00

16.92

estimate

—

(3022313) Gas panel - Capillary blood

1.81

0.77

1.8

3.4

—

(3009261) Glucose [Presence] in Urine by Test strip

455

1.37

0.76

4.4

3.5

0.00

estimate

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.66

0.76

1.5

2.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

201

0.64

0.75

1.6

1.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1.81

0.73

1.1

1.5

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.81

0.73

1.4

1.1

—

(3000991) Gas panel - Venous blood

1.67

0.72

7.5

9.5

—

(3015736) pH of Urine

379

1.36

0.72

3.6

3.3

6.48

6.18

1.06

206

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

138

1.47

0.69

4.1

4.2

23.05

20.37

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1.90

0.69

2.4

1.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.56

0.69

2.4

1.6

—

(3019060) Gas panel - Arterial blood

1.68

0.68

1.1

4.1

—

(3020891) Body temperature

1.83

0.67

1.4

3.2

37.02

37.00

°c

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

412

1.33

0.66

3.4

3.1

115.51

94.39

ug/l

0.53

391

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1.76

0.64

1.0

2.7

172.00

170.79

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

149

1.43

0.64

3.8

2.7

0.71

0.73

e6/l

—

(3018095) Leukocytes [#/volume] in Urine

307

1.34

0.64

6.4

3.9

36.90

162.30

e6/l

0.68

202

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

382

0.76

0.59

3.2

2.7

—

estimate

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

1.76

0.59

2.5

2.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

244

1.34

0.58

4.6

3.1

0.00

estimate

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1.62

0.55

1.3

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

100

0.57

0.55

1.5

—

(36304419) Bacteria [Presence] in Urine

218

1.33

0.55

5.0

3.0

—

estimate

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.53

0.53

2.4

3.6

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1.45

0.53

1.7

1.3

—

(3025941) Bacteria identified in Stool by Culture

1.56

0.49

1.3

1.2

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1.46

0.47

2.7

11.7

0.63

0.62

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1.46

0.47

2.9

11.7

1.20

1.23

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.43

0.46

4.4

9.3

21.76

25.68

mmol/l

—

(3009508) Creatinine [Moles/volume] in Urine

252

1.28

0.46

3.7

3.4

6.74

8.05

mmol/l

0.90

220

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.39

0.42

1.7

1.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

217

1.27

0.41

1.5

1.4

2.60

2.35

g/l

0.32

133

(3018418) pH of Serum or Plasma

236

1.26

0.41

9.5

3.9

7.37

7.40

1.60

170

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

1.0

—

4.10

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.41

0.0

1.2

—

(3002256) Pathology report gross observation

1.38

0.40

1.2

1.3

—

(3032080) INR in Blood by Coagulation assay

316

1.22

0.37

15.0

13.9

1.19

1.21

inr

0.07

263

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.35

0.34

1.8

1.9

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.40

0.32

1.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

620

1.21

0.32

3.9

3.6

—

(3000492) Spirometry study

1.33

0.31

1.3

1.5

—

(3035941) MCH [Entitic mass]

895

0.77

0.31

26.4

22.5

30.44

30.22

0.70

889

(3026361) Erythrocytes [#/volume] in Blood

895

0.77

0.31

26.5

22.6

4.60

4.55

e12/l

0.41

880

(3010813) Leukocytes [#/volume] in Blood

895

0.77

0.31

26.6

22.6

6.71

6.68

e9/l

0.07

880

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

895

0.77

0.31

26.9

23.1

41.59

40.86

1.03

889

(3024731) MCV [Entitic mean volume] in Red Blood Cells

895

0.77

0.31

26.5

22.5

90.74

90.43

0.28

889

(3000963) Hemoglobin [Mass/volume] in Blood

895

0.77

0.31

26.8

22.7

139.32

136.68

g/l

1.08

889

(3007461) Platelets [#/volume] in Blood

894

0.79

0.30

26.5

22.6

255.93

253.83

e9/l

0.13

881

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

705

1.22

0.29

24.5

19.1

334.49

332.97

g/l

0.80

705

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

352

1.18

0.29

2.1

2.0

103.16

98.75

pmol/l

0.16

183

(4035726) Immunohistochemistry procedure

1.25

0.28

1.4

1.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

823

1.31

0.27

20.1

14.9

16.27

21.75

mg/l

1.46

657

(3014576) Chloride [Moles/volume] in Serum or Plasma

114

1.27

0.27

2.9

7.1

103.57

104.82

mmol/l

0.59

114

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

771

1.24

0.26

4.9

4.5

5.70

5.81

mmol/l

0.36

721

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

750

1.22

0.26

5.5

5.6

37.80

38.75

mmol/mol

0.37

714

(3027945) Reticulocytes/Erythrocytes in Blood

0.70

0.25

1.5

3.7

1.30

1.85

—

(40768804) Tissue Pathology biopsy report

317

1.16

0.24

2.6

1.9

—

(3003694) ABO and Rh group [Type] in Blood

260

0.85

0.23

1.8

1.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1.26

0.23

1.2

3.6

0.94

0.83

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.26

0.22

1.6

2.1

—

(40761511) CBC panel - Blood by Automated count

848

1.31

0.22

12.1

12.6

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

0.00

0.21

0.0

1.1

—

0.66

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

2.75

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.0

—

(3045716) Anion gap in Serum or Plasma by calculation

0.00

0.21

0.0

1.8

—

9.92

—

(4146454) Self-monitoring of blood glucose

0.00

0.21

0.0

3.1

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.21

0.0

3.2

—

106.00

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

0.21

0.0

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.21

0.0

3.2

—

1.20

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

0.00

0.21

0.0

1.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.4

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.21

0.0

3.2

—

3.95

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.16

0.19

1.2

1.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

194

0.85

0.19

2.3

2.4

—

(3008898) HLA-B27 [Presence]

1.22

0.18

1.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

129

1.19

0.18

1.7

1.9

—

(3044640) Blood type and Crossmatch panel - Blood

265

0.87

0.17

2.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

151

0.84

0.17

1.5

1.6

—

(3019225) pH of Specimen

1.16

0.17

3.6

4.7

7.38

7.39

—

(36660697) Celiac disease serology panel - Serum

1.23

0.16

1.3

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

222

0.87

0.15

5.7

4.4

3.35

11.92

mg/mmol

2.09

148

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

151

1.15

0.14

1.2

1.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

761

1.14

0.13

4.2

3.9

1.32

1.26

mmol/l

0.35

713

(21494755) Public health laboratory ask at order entry panel

116

0.85

0.12

1.1

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

125

0.86

0.11

1.7

1.9

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1.14

0.10

1.2

3.5

2.30

1.56

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.04

0.09

1.8

1.4

—

(40761535) Cells panel - Urine sediment

1.14

0.09

2.3

3.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

146

1.12

0.09

1.3

1.6

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1.08

0.09

1.3

1.8

1.43

4.97

ug/l

—

(3026008) Bacteria identified in Urine by Culture

225

1.09

0.08

5.3

3.0

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

862

0.87

0.08

13.2

11.5

30.25

27.44

u/l

0.63

846

(40761536) Microorganisms panel - Urine sediment

1.05

0.08

4.4

3.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

108

1.13

0.07

3.2

3.0

0.63

0.74

ug/l

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

858

0.91

0.03

22.5

17.8

80.09

74.80

umol/l

0.41

849

(1761868) Lipid panel - Serum or Plasma

339

0.96

0.03

3.7

3.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

227

0.96

0.01

2.1

—

(3029937) Albumin [Presence] in Urine by Test strip

243

1.04

0.01

5.9

3.2

0.00

estimate

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

206

0.96

0.00

2.0

2.59

2.74

mg/l

0.17

183

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

818

1.02

0.00

5.4

5.1

2.88

2.81

mmol/l

0.25

770

(3042936) Bacteria identified in Isolate by Culture

127

1.03

0.00

3.5

1.9

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

804

0.97

0.00

20.4

16.1

139.70

139.72

mmol/l

0.02

788

(3023103) Potassium [Moles/volume] in Serum or Plasma

804

0.97

0.00

20.5

16.2

3.98

3.93

mmol/l

1.33

786

(40768797) Stomach Pathology biopsy report

105

0.95

0.00

1.4

1.3

—

(3012516) Albumin [Mass/volume] in Urine

214

0.98

0.00

4.5

3.7

15.81

72.58

mg/l

2.33

147

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.0

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.8

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.0

1.4

—

119.86

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.00

0.0

1.6

—

65.20

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3044927) Protein electrophoresis panel - Urine

0.00

0.0

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.0

1.2

—

(3017354) Segmented neutrophils/Leukocytes in Blood

0.00

0.0

4.4

—

68.60

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

0.0

1.4

—

109.94

—

(3009871) Measles virus Ab [Titer] in Serum

0.00

0.0

1.8

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

0.00

0.0

1.2

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.0

1.0

—

174.20

—

(40768441) Liver Pathology biopsy report

0.00

0.0

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

0.00

0.0

1.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

0.0

2.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.8

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

0.00

0.0

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

0.00

0.0

1.5

—

117.25

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

0.00

0.0

1.9

—

8.44

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.00

0.0

1.0

—

0.27

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.7

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.00

0.0

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.0

4.4

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

31.13

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

4.38

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.8

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.00

0.0

1.1

—

159.64

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

0.0

1.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.00

0.0

1.4

—

(4211845) Urine protein measurement

0.00

0.0

1.0

—

(37208534) Antinuclear antibody arbitrary concentration in serum

0.00

0.0

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.0

1.0

—

(4281824) Cell count and differential, peritoneal fluid

0.00

0.0

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.00

-0.00

0.0

2.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

0.90

-0.00

3.3

5.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

0.00

-0.00

0.0

2.3

—

1.29

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.00

-0.00

0.0

2.7

—

(21491868) Cryoglobulin [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

4.8

—

299.00

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

0.89

-0.00

2.4

1.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.8

—

(3045142) Bone marrow Pathology biopsy report

0.00

-0.00

0.0

1.3

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

0.00

-0.00

0.0

1.4

—

23.44

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

6.0

—

25.52

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

-0.00

0.0

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.00

-0.00

0.0

1.0

—

1.36

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.00

-0.00

0.0

1.0

—

(21494434) Karyotype in Bone marrow

0.00

-0.00

0.0

1.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.3

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_EFFEC_OTHER_DEPRI – Effects of other deprivation

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Effects of other deprivation

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Effects of other deprivation (ST19_EFFEC_OTHER_DEPRI)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints